44 results for “Skeletal muscle”
Synthetic muscle-specific promoter (also called C5-12) built by combinatorially assembling multiple copies of E-box, MEF-2, TEF-1, and SRE transcription-factor binding sites upstream of a minimal promoter, then screening clones for maximal activity. Drives high-level expression restricted to skeletal and cardiac muscle, exceeding natural muscle and viral promoters in differentiated muscle cells.
Skeletal muscle-targeted PHP variant with reduced off-target CNS and hepatic transduction.
Synthetic 770 bp hybrid promoter combining a 190 bp murine alpha-myosin heavy chain (alphaMHC) enhancer with a 570 bp abbreviated muscle creatine kinase (MCK) regulatory cassette, giving high-level expression in both skeletal and cardiac muscle. The strongest characterized muscle-specific cassette for AAV-mediated micro-dystrophin delivery in Duchenne muscular dystrophy gene therapy, including the FDA-approved product Elevidys.
Human ACTA1 (skeletal muscle alpha-actin) gene promoter, driving transcription almost exclusively in differentiated skeletal myofibers. The 5'-flanking region contains at least three synergistic regulatory subdomains and produces high-level expression in myotubes while remaining inactive in nonmuscle cell lines, giving strong skeletal-muscle-restricted expression for gene delivery constructs.
Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle
Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells
A compact unc45b-promoter drives muscle-specific expression in zebrafish and mouse
Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants